Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Annals of Surgical Oncology|January 14, 2015
Quality of Life in Platinum-Sensitive Recurrent Ovarian Cancer: Chemotherapy Versus Surgery Plus ChemotherapyFrancesco Plotti, Giuseppe Scaletta, Alessia Aloisi, et al.
Expert Review of Anticancer Therapy|August 1, 2017
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic reviewGiuseppe Scaletta, Francesco Plotti, Daniela Luvero, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2017
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian CancerFrancesco Plotti, Giuseppe Scaletta, Stella Capriglione, et al.
Journal of Clinical Medicine|November 25, 2023
Impact of COVID-19 Pandemic on the Diagnostic and Therapeutic Management of Endometrial Cancer: A Monocentric Retrospective Comparative StudyFrancesco Plotti, Adele Silvagni, Roberto Montera, et al.
The American Journal of Cardiology|November 20, 2023
Cardiovascular Effects of Chronic Hormone Therapy: Study on Olympic Female AthletesGiuseppe Di Gioia, Simone Pasquale Crispino, Viviana Maestrini, et al.
Journal of Clinical Medicine|June 27, 2024
The Efficacy of CO2 Vaginal Laser in the Treatment of Recurrent, Post-Coital and Interstitial Cystitis: A Multicentric Prospective StudyDaniela Luvero, Adele Silvagni, Anna Maria Angioli, et al.
Medical Oncology (Northwood, London, England)|April 9, 2017
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent datasetFrancesco Plotti, Stella Capriglione, Corrado Terranova, et al.
Gynecologic Oncology|July 24, 2012
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancerRoberto Angioli, Francesco Plotti, Roberto Montera, et al.
ESMO Open|August 30, 2017
Switching from standard to dose-dense chemotherapy in front-line treatment of advanced ovarian cancer: a retrospective study of feasibility and efficacyAndrea Milani, Rebecca Kristeleit, Mary McCormack, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 17, 2018
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center surveyFrancesco Plotti, Stella Capriglione, Giuseppe Scaletta, et al.
Pageof 8